Necessity of time series analysis and effects of direct-acting antivirals on HCV patients awaiting liver transplantation

被引：0
|
作者：
Liu, Xibei [1 ]
Shen, Jay J. [2 ]
Kim, Sun Jung [3 ]
Lee, Yong-Jae [4 ]
Kwak, Myung [5 ]
Yoo, Ji Won [6 ]
机构：
[1] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA
[2] Univ Nevada, Dept Healthcare Adm & Policy, Las Vegas, NV 89154 USA
[3] Soon Chun Hyang Univ, Dept Hlth Adm & Management, Asan, Chungcheongnam, South Korea
[4] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea
[5] Seoul Med Ctr, Dept Emergency Med, Seoul, South Korea
[6] Univ Nevada, Sch Med, Dept Internal Med, 1701 W Charleston Blvd,230, Las Vegas, NV 89102 USA
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 03期
关键词：
ALLOCATION;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：628 / 629
页数：3
相关论文
共 50 条
  • [41] Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals
    Naggie, Susanna
    Sulkowski, Mark S.
    GASTROENTEROLOGY, 2012, 142 (06) : 1324 - +
  • [42] Virological patterns of HCV-patients with failure to second generation direct-acting antivirals
    Occhiello, Laura
    Starace, Mario
    Pisaturo, Mariantonietta
    Minichini, Carmine
    de Pascalis, Stefania
    Macera, Margherita
    di Fraia, Alessandra
    Alessio, Loredana
    Messina, Vincenzo
    Claar, Ernesto
    Ascione, Tiziana
    Marrone, Aldo
    Gentile, Ivan
    D'Adamo, Giuseppe
    Gaeta, Giovanni Battista
    Coppola, Nicola
    JOURNAL OF HEPATOLOGY, 2020, 73 : S350 - S350
  • [43] Uptake of HCV Therapy in HIV/HCV Coinfected Patients across Europe in the Era of Direct-Acting Antivirals
    Peters, Lars
    HEPATOLOGY, 2016, 64 : 969A - 969A
  • [44] Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals
    Argalia, Giulio
    Tarantino, Giuseppe
    Ventura, Claudio
    Campioni, Daniele
    Tagliati, Corrado
    Guardati, Paola
    Kostandini, Alba
    Marzioni, Marco
    Giuseppetti, Gian Marco
    Giovagnoni, Andrea
    RADIOLOGIA MEDICA, 2021, 126 (06): : 894 - 899
  • [45] HCV RNA assay sensitivity impacts the management of patients treated with direct-acting antivirals
    Cloherty, Gavin
    Cohen, Daniel
    Sarrazin, Christoph
    Wedemeyer, Heiner
    Chevaliez, Stephane
    Herman, Christine
    Bernstein, Barry
    Pawlotsky, Jean Michel
    ANTIVIRAL THERAPY, 2015, 20 (02) : 177 - 183
  • [46] Effects of DAAs (direct-acting antivirals) on cardiac function and structure in hepatitis c (HCV) patients with low-mild liver fibrosis
    Dalbeni, A.
    Romano, S.
    Bevilacqua, M.
    Imbalzano, E.
    Piccoli, A.
    Mantovani, A.
    Benati, M.
    Montagnana, M.
    Torin, G.
    Monaco, C.
    Donato, A.
    Prat, L. Iogna
    Tagetti, A.
    Paon, V.
    Ribichini, F.
    Minuz, P.
    Fava, C.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E58 - E58
  • [47] Human genetics of HCV infection phenotypes in the era of direct-acting antivirals
    Pierre Nahon
    Aurélie Cobat
    Human Genetics, 2020, 139 : 855 - 863
  • [48] Management of acute HCV in the era of direct-acting antivirals: implications for elimination
    Martinello, Marianne
    Matthews, Gail V.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (04): : 256 - 257
  • [49] Reported safety of HCV direct-acting antivirals with opioids: 2017 to 2021
    Martinez, Anthony
    Khan, Tipu
    Dylla, Doug
    Marcinak, John
    Collins, Michelle
    Saget, Brad
    Conway, Brian
    JOURNAL OF HEPATOLOGY, 2022, 77 : S596 - S596
  • [50] Effects of Direct-Acting Antivirals on Insulin Resistance in Hepatitis C Patients
    Moon, Jooyoung
    Moon, Hanna
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 46 - 46
12345